Reference
Tapper EB, et al. The optimal timing of hepatitis C therapy in transplant eligible patients with Child B and C Cirrhosis: A Cost-Effectiveness Analysis. Transplantation : 4 Aug 2016. Available from: URL: http://doi.org/10.1097/TP.0000000000001400
Rights and permissions
About this article
Cite this article
HCV therapy before liver transplant "superior strategy". PharmacoEcon Outcomes News 760, 18 (2016). https://doi.org/10.1007/s40274-016-3319-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3319-3